Clinical Trial Update: Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

View source ↗

Summary

A pooled analysis of BLISS-52 and BLISS-76 evaluates belimumab effectiveness in a subpopulation of systemic lupus erythematosus patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED